Ethyl 4-chloroimidazo[1,5-a]quinoxaline-3-carboxylate, 95%, 500mg

(E)-2-(2,6-Dichlorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 250mg

(3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)methanol, 95%, 250mg

N,N-Diisopropyléthylamine, PEPTIPURE®, min 99,5%, pour la synthèse peptidique, 1 l

fmoc-tic-oh, 98.0%, 5g

Boron Trifluoride - Ethyl Ether Complex>98.0%(W)25mL

Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate, 95%, 1g

TERT-BUTYL (4-AMINO-3-FLUOROPHENYL)CARBAMATE, 95.0%, 25g

ETHYL 8-METHYLIMIDAZO[1,2-A]PYRAZINE-3-CARBOXYLATE, 95.0%, 1g

Benzyl Methyl Sulfide>98.0%(GC)5mL

Dexpramipexole dihydrochloride, 99.71%, 50mg

Nonadecyl-benzen, 98%, 5g

PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIOL, 95.0%, 25g